| AMARILLO, Texas, Nov. 3, 2011 /PRNewswire/ -- Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced today that a new audio interview with ChartPoppers.com is now available (AMAR). ABI is developing low-dose oral interferon for human and animal health. The product is safe, inexpensive, stable at room temperature, and easy-to-administer; and it works by modulating the immune system to help regulate interferon sensitive genes. The company asserts that low dose oral interferon can achieve many of the ...continued AMAR biotechnology pharmaceutical biotech |
Thursday, November 3, 2011
Amarillo Biosciences' Live Interview Available on ChartPoppers.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment